An update on autoinflammatory diseases: inflammasomopathies
- Author(s)
- Harapas, CR; Steiner, A; Davidson, S; Masters, SL;
- Details
- Publication Year 2018-05-30,Volume 20,Issue #7,Page 40
- Journal Title
- Current Rheumatology Reports
- Publication Type
- Journal Article
- Abstract
- PURPOSE OF REVIEW: Autoinflammatory diseases are driven by abnormal innate immune activation. In the case of inflammasomopathies, these are all attributable to activation of an inflammasome complex, nucleated by an innate immune sensor such as NLRP3. This review will focus on recent advances that have helped to elucidate the role of three other sensors (NLRP1, NLRC4 and pyrin) which can also cause inflammasomopathies. RECENT FINDINGS: Mutations in pyrin (S242R or E244K) destroy an inhibitory 14-3-3 binding site and result in the newly characterised disease pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND). Moreover, a separate autoinflammatory disease driven by mevalonate kinase deficiency leads to defective RhoGTPase prenylation and subsequent loss of pyrin S242R phosphorylation, suggesting a shared mechanism of disease. Other inflammasomes such as NLRP1 and NLRC4 have had novel mutations described recently, which inform about the specific domains required for activation and autoinhibition. This review covers recent advances in the study of inflammasomopathies, focussing on gene discoveries that elucidate new pathogenic mechanisms.
- Publisher
- Springer
- Research Division(s)
- Infection And Immunity
- PubMed ID
- 29846819
- Publisher's Version
- https://doi.org/10.1007/s11926-018-0750-4
- NHMRC Grants
- NHMRC/1144282, NHMRC/1142354, NHMRC/1099262, NHMRC/1143412,
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2018-06-26 12:34:45
Last Modified: 2018-06-26 02:00:00